NDC 58809-123

Vanapain

Choline Salicylate, Caffeine

Vanapain is a Oral Liquid in the Human Otc Drug category. It is labeled and distributed by Gm Pharmaceuticals, Inc.. The primary component is Choline Salicylate; Caffeine.

• Product ID: 58809-123_181986d4-bf7c-58cd-e054-00144ff8d46c
• NDC: 58809-123
• Product Type: Human Otc Drug
• Proprietary Name: Vanapain
• Generic Name: Choline Salicylate, Caffeine
• Dosage Form: Liquid
• Route of Administration: ORAL
• Marketing Start Date: 2013-07-22
• Marketing Category: OTC MONOGRAPH NOT FINAL / OTC MONOGRAPH NOT FINAL
• Application Number: part343
• Labeler Name: GM Pharmaceuticals, Inc.
• Substance Name: CHOLINE SALICYLATE; CAFFEINE
• Active Ingredient Strength: 870 mg/57mL; mg/57mL
• NDC Exclude Flag: E
• Listing Certified Through: 2017-12-31

Packaging

NDC 58809-123-60

57 mL in 1 BOTTLE, PLASTIC (58809-123-60)

• Marketing Start Date: 2013-07-22
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 58809-123-60 [58809012360]

Vanapain LIQUID

• Marketing Category: OTC monograph not final
• Application Number: part343
• Product Type: HUMAN OTC DRUG
• Marketing Start Date: 2013-07-22
• Inactivation Date: 2020-01-31

Drug Details

Active Ingredients

Ingredient	Strength
CHOLINE SALICYLATE	870 mg/57mL

OpenFDA Data

• SPL SET ID: 43ed6c9a-5011-4b08-ba1d-c94f8074c31d
• Manufacturer:
  • GM Pharmaceuticals, Inc.
• UNII:
  • 3G6A5W338E
  • KD510K1IQW
• RxNorm Concept Unique ID - RxCUI:
  • 1664664